Skip to main content

Advertisement

Log in

Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: a nationwide cross-sectional study

  • ORIGINAL PAPER
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Previous studies found conflicting results about associations of vitiligo with different autoimmune diseases. To evaluate associations of vitiligo with multiple autoimmune diseases. A cross-sectional study representative of 612,084,148 US patients from the Nationwide Emergency Department Sample (NEDS) 2015–2019 was performed. Vitiligo and autoimmune diseases were identified using International Classification of Diseases-10 codes. The most frequent autoimmune disorders in patients with vitiligo were type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus (SLE), autoimmune thyroiditis, Addison's disease, and systemic sclerosis (SSc). Vitiligo was associated with any autoimmune disorder (adjusted odds ratio [95% confidence interval] 1.45 [1.32–1.58]). Cutaneous disorders with largest effect-sizes were alopecia areata (186.22 [115.31–300.72]) and SSc (32.13 [25.28–40.82]). Non-cutaneous comorbidities with largest effect-sizes were primary sclerosing cholangitis (43.12 [18.98–97.99]), pernicious anemia (41.26 [31.66–53.78]), Addison's disease (33.85 [26.68–42.9]), and autoimmune thyroiditis (31.65 [26.34–38.02]). Vitiligo is associated with multiple cutaneous and non-cutaneous autoimmune diseases, especially in females and older age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The data that support the findings of this study is available for purchase at https://hcup-us.ahrq.gov/tech_assist/centdist.jsp (hcup@ahrq.gov) under the name of “The Nationwide Emergency Department Sample (NEDS).” Restrictions apply to the availability of these data, which were used under license for this study.

References

  1. Bergqvist C, Ezzedine K (2020) Vitiligo: a review. Dermatology 236(6):571–592. https://doi.org/10.1159/000506103

    Article  PubMed  Google Scholar 

  2. Krüger C, Schallreuter KU (2012) A review of the worldwide prevalence of vitiligo in children/adolescents and adults: worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 51(10):1206–1212. https://doi.org/10.1111/j.1365-4632.2011.05377.x

    Article  PubMed  Google Scholar 

  3. Sheth VM, Guo Y, Qureshi AA (2013) Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology 227(4):311–315. https://doi.org/10.1159/000354607

    Article  PubMed  Google Scholar 

  4. Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I (2016) Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol 74(2):295–302. https://doi.org/10.1016/j.jaad.2015.08.063

    Article  PubMed  Google Scholar 

  5. Chen YT, Chen YJ, Hwang CY et al (2015) Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol 29(7):1362–1369. https://doi.org/10.1111/jdv.12870

    Article  CAS  PubMed  Google Scholar 

  6. Tang L, Li F, Xu F et al (2021) Prevalence of vitiligo and associated comorbidities in adults in Shanghai, China: a community-based, cross-sectional survey. Ann Palliat Med 10(7):8103–8111. https://doi.org/10.21037/apm-21-1738

    Article  PubMed  Google Scholar 

  7. Poojary SA (2011) Vitiligo and associated autoimmune disorders: a retrospective hospital-based study in Mumbai. India Allergol Immunopathol (Madr) 39(6):356–361. https://doi.org/10.1016/j.aller.2010.12.007

    Article  CAS  PubMed  Google Scholar 

  8. Lumley T (2004) Analysis of complex survey samples. J Stat Softw 9(1):1–19

    Google Scholar 

  9. R Core Team (2022) R: a language and environment for statistical computing. https://www.R-project.org/

  10. Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57(10):1157–1164. https://doi.org/10.1111/ijd.14055

    Article  PubMed  Google Scholar 

  11. Silverberg JI, Silverberg NB (2013) Association between vitiligo and atopic disorders: a pilot study. JAMA Dermatol 149(8):963. https://doi.org/10.1001/jamadermatol.2013.4228

    Article  Google Scholar 

  12. D’Arino A, Picardo M, Truglio M, Pacifico A, Iacovelli P (2021) Metabolic comorbidities in vitiligo: a brief review and report of new data from a single-center experience. Int J Mol Sci 22(16):8820. https://doi.org/10.3390/ijms22168820

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y (2016) Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 52(2):205–212. https://doi.org/10.4415/ANN_16_02_12

    Article  CAS  PubMed  Google Scholar 

  14. Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T (2011) Generalized vitiligo associated autoimmune diseases in japanese patients their families. Allergol Int 60(4):505–508. https://doi.org/10.2332/allergolint.11-OA-0303

    Article  PubMed  Google Scholar 

  15. Amerio P, Di Rollo D, Carbone A et al (2010) Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol 20(3):354–358. https://doi.org/10.1684/ejd.2009.0939

    Article  PubMed  Google Scholar 

  16. Lee H, Lee MH, Lee DY et al (2015) Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J 56(3):719. https://doi.org/10.3349/ymj.2015.56.3.719

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lause M, Kamboj A, Fernandez FE (2017) Dermatologic manifestations of endocrine disorders. Transl Pediatr 6(4):300–312. https://doi.org/10.21037/tp.2017.09.08

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nakouti T, Cholongitas E (2014) Is there an association between vitiligo and primary sclerosing cholangitis? Correspondence. Int J Dermatol 53(1):e14–e16. https://doi.org/10.1111/j.1365-4632.2011.05407.x

    Article  PubMed  Google Scholar 

  19. Terziroli Beretta-Piccoli B, Invernizzi P, Gershwin ME, Mainetti C (2017) Skin manifestations associated with autoimmune liver diseases: a systematic review. Clin Rev Allergy Immunol 53(3):394–412. https://doi.org/10.1007/s12016-017-8649-9

    Article  CAS  PubMed  Google Scholar 

  20. Rork JF, Rashighi M, Harris JE (2016) Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr 28(4):463–469. https://doi.org/10.1097/MOP.0000000000000375

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bergqvist C, Ezzedine K (2021) Vitiligo: a focus on pathogenesis and its therapeutic implications. J Dermatol 48(3):252–270. https://doi.org/10.1111/1346-8138.15743

    Article  CAS  PubMed  Google Scholar 

  22. Martins LT, Frigeri HR, Castro CCS, Mira MT (2020) Association study between vitiligo and autoimmune-related genes CYP27B1, REL, TNFAIP3, IL2 and IL21. Exp Dermatol 29(6):535–538. https://doi.org/10.1111/exd.14100

    Article  CAS  PubMed  Google Scholar 

  23. Mohan GC, Silverberg JI (2015) Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol 151(5):522–528

    Article  PubMed  Google Scholar 

  24. Patel KR, Singam V, Rastogi S, Lee HH, Silverberg NB, Silverberg JI (2019) Association of vitiligo with hospitalization for mental health disorders in US adults. J Eur Acad Dermatol Venereol 33(1):191–197

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

JRD, MSZ and JIS performed the data analysis and interpretation, drafted the original manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Jonathan I. Silverberg.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Consent for the publication of all patient photographs and medical information

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 24 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rios-Duarte, J.A., Sanchez-Zapata, M.J. & Silverberg, J.I. Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: a nationwide cross-sectional study. Arch Dermatol Res 315, 2597–2603 (2023). https://doi.org/10.1007/s00403-023-02661-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-023-02661-y

Keywords

Navigation